Evidence map›Paper›PMID 35978338›Full record

ArticleTrials2022

Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice.

Shoba Dawson, Katie Banister, Katie Biggs, Seonaidh Cotton, Declan Devane, Heidi Gardner, Katie Gillies, Gosala Gopalakrishnan, Talia Isaacs, Kamlesh Khunti and 11 more

Erratum issuedAbstract read
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Improving Diversity in Recruitment: Lessons Learned During the REACH Pregnancy Circles Pilot Trial.Health expectations : an international journal of public participation in health care and health policy · 2025
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Evidence-biased medicine? Applying a health equity lens to Sackett's methodological framework.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Shoba DawsonCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.
Katie BanisterHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
Katie BiggsSchool of Health and Related Research, University of Sheffield, Sheffield, S1 4DA, UK.
Seonaidh CottonHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
Declan DevaneHealth Research Board-Trials Methodology Research Network (HRB-TMRN), School of Nursing and Midwifery, National University of Ireland Galway, University Road, Galway, Ireland.
Heidi GardnerHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
Gosala GopalakrishnanDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Talia IsaacsUCL Centre for Applied Linguistics, IOE, UCL's Faculty of Education and Society, University College London, London, WC1H 0AL, UK.
Kamlesh KhuntiDiabetes Research Centre, College of Life Sciences, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK.
Alistair NicholSchool of Medicine, University College Dublin, Dublin, Ireland.
Adwoa ParkerYork Clinical Trials Unit, University of York, York, UK.
Amy M RussellWHO Disability Team, Geneva/ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Victoria ShepherdCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Frances ShielyHealth Research Board Clinical Research Facility and School of Public Health, University College Cork, Cork, Ireland.
Gillian ShorterDrug and Alcohol Research Network, Queen's University Belfast, Belfast, UK.
Bella StarlingPublic Programmes Team (now Vocal), Manchester University NHS Foundation Trust, Research & Innovation Division, The Nowgen Centre, 29 Grafton Street, Manchester, M13 9WU, UK.
Hywel WilliamsCentre of Evidence-Based Dermatology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK.
Andrew WillisNIHR ARC East Midlands, University of Leicester, Leicester, UK.
Miles D WithamNIHR Newcastle Biomedical Research Centre, Campus for Ageing and Vitality, Newcastle University and Newcastle upon Tyne NHS Trust, Newcastle, NE4 5PL, UK.
Shaun TreweekHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. streweek@mac.com.ORCID http://orcid.org/0000-0002-7239-7241

Funding

Chief Scientist Office HSRU1HCRW_ NIHR-FS(A)-2021Health Research Board HRB-TMRN-2017-2World Health Organization 001
6 · The paper itself

Abstract

Randomised trials, especially those intended to directly inform clinical practice and policy, should be designed to reflect all those who could benefit from the intervention under test should it prove effective. This does not always happen. The UK National Institute for Health and Care Research (NIHR) INCLUDE project identified many groups in the UK that are under-served by trials, including ethnic minorities.This guidance document presents four key recommendations for designing and running trials that include the ethnic groups needed by the trial. These are (1) ensure eligibility criteria and recruitment pathway do not limit participation in ways you do not intend, (2) ensure your trial materials are developed with inclusion in mind, (3) ensure staff are culturally competent and (4) build trusting partnerships with community organisations that work with ethnic minority groups. Each recommendation comes with best practice advice, public contributor testimonials, examples of the inclusion problem tackled by the recommendation, or strategies to mitigate the problem, as well as a collection of resources to support implementation of the recommendations.We encourage trial teams to follow the recommendations and, where possible, evaluate the strategies they use to implement them. Finally, while our primary audience is those designing, running and reporting trials, we hope funders, grant reviewers and approvals agencies may also find our guidance useful.

Indexed as

EthnicityMinority GroupsEthnic and Racial MinoritiesHumansRandomized Controlled Trials as TopicTrustEthnic minorityInclusionRandomised trialsRecruitmentRetentionTrial methodology

Identifiers

PMID35978338
PMCPMC9383663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.